Galmed Approves $10 million Cash Reserve for Purchase of Digital Assets
2025-08-25 11:56:35
Biopharmaceutical company Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) today announced that its Board of Directors has approved a digital asset management strategy as part of a new financial investment policy and capital allocation plan. To this end, the Board has established the Cryptocurrency Committee, which is responsible for evaluating and, where appropriate, overseeing the implementation of any activities related to cryptocurrency investments, including the potential use of up to 50% of the company's cash reserves to purchase digital assets, currently around $10 million.
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
Galmed批准将1000万美元的现金储备用于购买数字资产Next article：
比特大陆前高管将在 YZi Labs 的支持下成立 BNB 资金公司
